Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBRAIN: Methylphenidate for Cancer-related Fatigue in Pediatric Brain Tumor Survivors
NCT06905587Phase 3Recruiting
- Sponsor
- University Hospital Odense
- Start
- Sep 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate hydrochloride extended-release chewable tablet in cancer-related fatigue (CRF), sponsored by University Hospital Odense. Started Sep 2025; status: recruiting.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT06905587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905587.